meet stentra™
kallisio introduces a breakthrough in radiation therapy with our 3D-printed, patient-specific immobilization device, designed to shield head and neck patients from radiation harm. Developed in collaboration with MD Anderson, our scalable, reimbursable, and custom-fit solution offers unmatched protection for Organs at Risk (OARs), enabling radoncs to administer the highest effective dose. Our patented, FDA-cleared device is revolutionizing patient care and is available now.
01
Precision in Treatment
The stentra™ product offers a patient-specific solution, facilitating precise and targeted radiation therapy while minimizing adverse effects.
02
Innovative Toxicity Management
Kallisio's stentra™ introduces a groundbreaking approach to protecting healthy tissue during radiation therapy, enhancing the overall quality of patient care.
03
Proven Readiness for Human Use
FDA clearance signifies that the stentra™ device has undergone rigorous testing, demonstrating its readiness for use in human patients.
